NASDAQ · Analyst Forecast

Clover Health Investments, Corp. (CLOV) Stock Forecast & Price Target

$4.93 NASDAQ: CLOV Market Cap $2.62B

Price as of Nov 16, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 15, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Clover Health Investments, Corp. (CLOV), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Clover Health Investments, Corp., analysts forecast revenue rising from $1.90B in 2025 to $5.14B in 2030; the average estimate for 2030 earnings per share is $0.31; with published estimates ranging from $0.30 to $0.32; 4 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$4.93
Consensus targetThe average of the price targets analysts have published.$5.63
Median targetThe middle target, less affected by a single outlier.$5.75
Highest targetThe most optimistic published target.$6.00
Lowest targetThe most pessimistic published target.$5.00
Difference from priceHow far the consensus target sits from today’s price.+14.2%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$1.84B$1.90B$1.95B2
2026$2.89B$2.99B$3.06B3
2027$3.54B$3.66B$3.75B3
2028$3.92B$4.28B$4.59B4
2029$4.33B$4.48B$4.59B2
2030$4.97B$5.14B$5.27B2

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$0.18−$0.17−$0.172
2026$0.06$0.06$0.063
2027$0.12$0.12$0.123
2028$0.12$0.19$0.254
2029$0.25$0.26$0.272
2030$0.30$0.31$0.322

Clover Health Investments, Corp. (CLOV) forecast — frequently asked questions

What is the analyst price target for Clover Health Investments, Corp.?

Analysts covering Clover Health Investments, Corp. (CLOV) have a consensus price target of $5.63, 14.2% above the current price of $4.93. Published targets range from $5.00 to $6.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Clover Health Investments, Corp.'s earnings?

The average analyst estimate for Clover Health Investments, Corp. (CLOV) earnings per share in 2030 is 0.31, with individual estimates between 0.30 and 0.32.

How much revenue is Clover Health Investments, Corp. expected to make?

Analysts forecast Clover Health Investments, Corp. (CLOV) revenue of $5.14B in 2030, based on 2 published estimates.

How many analysts cover CLOV?

4 analysts contribute estimates for Clover Health Investments, Corp. (CLOV). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Healthcare Plans stocks

UNH forecastCVS forecastELV forecastCI forecastHUM forecastCNC forecastMOH forecastOSCR forecastPGNY forecastALHC forecastAll Medical - Healthcare Plans stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.